Industry: 2022 will become the "Year of Procurement of Traditional Chinese Medicine"

"Including Chinese patent medicines, on the basis that some provinces have organized alliance procurement last year, the scope should be further expanded in an orderly manner this year
.
" This is the news from the regular policy briefing on February 11, which released this year's centralized procurement of Chinese patent medicines.
Expanded signal
.
The centralized procurement of proprietary Chinese medicines has long been followed
.
For example, Jinhua City in Zhejiang Province, Qinghai City, Puyang City in Henan Province and other places have already conducted pilot projects for the centralized procurement of Chinese patent medicines, and have achieved certain results
.
In November 2021, 19 provinces (autonomous regions and municipalities) led by Hubei announced the results of the centralized procurement of Chinese patent medicines.
A total of 97 companies and 111 products were to be selected, and the selected Chinese patent medicine products dropped by an average of 42.
27%
.
At the same time, in response to the issue of centralized procurement of traditional Chinese medicine formula granules that has attracted much attention in the industry, the National Medical Insurance Administration will reply in 2021: the next step will be to work with relevant departments on the basis of improving the quality evaluation standards for Chinese patent medicines and formula granules, adhere to quality first, and focus on clinical practice.
Demand-oriented, starting from high-priced and large-scale varieties, scientifically and prudently promote the reform of centralized procurement of Chinese patent medicines and formula granules
.
At the end of the same year, the “Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine” of the two departments clearly stated that it encouraged the inclusion of traditional Chinese medicine formula granules purchased by public medical institutions into the provincial centralized pharmaceutical procurement platform for online transactions to promote open and transparent transactions
.
At present, many provinces and cities have begun to carry out the centralized procurement of traditional Chinese medicine formula granules
.
For example, Guangdong Province launched a third-party electronic trading platform for Chinese herbal decoction pieces as early as 2020; in 2021, Shanghai Sunshine Purchasing Network issued a document stating that "sunshine procurement" will be fully implemented for Chinese herbal medicine pieces (including formula granules); The Joint Purchasing Center issued a notice requiring that the traditional Chinese medicine formula granules that have completed the listing sales record, the cross-provincial sales record record in Fujian Province, and the traditional Chinese medicine formula granule production enterprises that were originally sold in the pilot program in the province before November 1, 2021.
Formula granules can be declared
.
In addition to Chinese patent medicine and Chinese medicine formula granules, Chinese herbal decoction pieces have also been included in the collection objects in many places
.
For example, in the medical insurance policy issued by Anhui Province in July 2021 to actively support the development of traditional Chinese medicine, it is mentioned that the exploration and development of centralized procurement of traditional Chinese medicine (TCM formula granules) in bulk
.
On January 6, 2022, the national inter-provincial traditional Chinese medicine (material) procurement alliance was launched for the first time.
It was initiated by the Shandong Provincial Medical Insurance Bureau and 11 provinces (autonomous regions and municipalities) across the country.
The first batch of participating areas covered 86 cities across the country, with more than 9,500 medical institution
.
This batch of joint procurement will focus on Chinese herbal decoction pieces (including formula granules), and the cumulative reported amount exceeds 10 billion yuan
.
This is also the first large-scale alliance procurement of Chinese herbal decoction pieces and Chinese herbal formula granules nationwide
.
It is reported that the first joint procurement transaction of the National Inter-Provincial Chinese Medicine (Material) Purchasing Alliance will be completed in the first quarter of this year.
The patients in the city have brought good news, and in the future, patients will be able to use traditional Chinese medicines of high quality and reasonable price, and further ensure the safety of patients' medication and clinical efficacy
.
At present, the centralized procurement of medicines organized by the state has been carried out to the sixth batch.
With the launch of the seventh batch of national procurement, the coverage of volume-based procurement is getting wider and wider, and Chinese patent medicines, Chinese herbal decoction pieces, and Chinese medicine formula granules will gradually be "targeted"
.
From the perspective of the industry, 2022 will become the "Year of Procurement of Traditional Chinese Medicines", and the centralized procurement of traditional Chinese medicines will be the general trend in the future
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.